US08773T1043 - Common Stock
It's time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning!
Better Therapeutics (BTTX)has applied for FDA Breakthrough Device Designation for its digital therapeutic to treat the liver conditions NASH and NAFLD. Read more here.
Better Therapeutics strengthens its financial position through an amendment to its debt facility and cost-saving measures.